Title: Lipid-Encapsulated Interfering RNA
Patent Number: 7,799,565
Filed: June 7, 2005
Lead Inventor: Ian MacLachlan, Protiva Biotherapeutics (Tekmira Pharmaceuticals)
The invention, the patent's abstract states, comprises "lipid-based formulations for delivering … nucleic acid-lipid particles comprising an interference RNA molecule to a cell, and assays for optimizing the delivery efficiency of such lipid-based formulations."